Targeted Antenatal Screening for Predicting Postpartum Thyroiditis and Its Evolution Into Permanent Hypothyroidism.
antenatal screening
autoimmune diseases
autoimmune thyroid diseases
fish consumption
postpartum
postpartum thyroiditis
pregnancy
thyroid autoimmunity
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2020
2020
Historique:
received:
04
02
2020
accepted:
27
03
2020
entrez:
5
5
2020
pubmed:
5
5
2020
medline:
29
5
2021
Statut:
epublish
Résumé
Postpartum thyroiditis (PPT) has a prevalence of 1-22%, with an ~50% rate of evolution into permanent hypothyroidism (PH). PPT risk is assessed by measuring serum thyroid antibodies during gestation, as 1/3-1/2 of Ab+ve pregnant women will develop PPT. Family and personal history positive for autoimmune non-thyroid diseases (AINTDT), and consumption of swordfish increases while consumption of small oily fish decreases the risk of PPT. Monitoring thyroid function in a very high-risk subgroup avoids the costs of the Ab-based universal screening. We aimed at identifying such subgroup in 412 women followed from week 7-11 of gestation to month 12 postpartum. At study entry, we measured serum TPOAb, TgAb, TSH, FT4, FT3, and evaluated seafood consumption, familial history for thyroid diseases and AINTD, and personal history for AINTD. We measured TSH, FT4, FT3 at 1.5, 3, 6, and 12 months postpartum. PPT occurred in 63 women (15.3%), and PH in 34/63 (54%). Based on positivity/negativity for the three histories, women were classified into 8 categories, with PPT rates of 3.8-100%. Seafood consumption allowed further separation of subgroups having different PPT risks. We considered 11 possible strategies, termed [a] through [k]. Strategy [a] consisted in omitting gestational screening, while performing universal postpartum monitoring with TSH and one thyroid hormone; strategy [k] consisted in selective gestational screening with TPOAb and TgAb, based on history and fish consumption, and selective postpartum monitoring in TPOAb and/or TgAb+ve women. The 100% sensitivity, specificity and diagnostic accuracy of strategy [a] were counterbalanced by the highest costs (Euro 32,960 or 523 per each PPT caught). The corresponding numbers for strategy [k] were 78, 95, 93%, and Euro 8,920 or 182/PPT caught. These savings stem from gestational screening being done in 186 women, and postpartum monitoring done in 65/186 women. One gestational screning-free strategy was the cheapest (Euro 2,080 or 83/PPT caught), because based on postpartum monitoring of only 26 women, but had the lowest sensitivity (40%). Identification of pregnant women having different risks for PPT is feasible, with the costless evaluation of history and seafood consumption driving gestational screening of thyroid antibody status and postpartum monitoring of thyroid function.
Identifiants
pubmed: 32362873
doi: 10.3389/fendo.2020.00220
pmc: PMC7180182
doi:
Substances chimiques
Autoantibodies
0
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
220Informations de copyright
Copyright © 2020 Benvenga.
Références
J Endocrinol Invest. 2008 Dec;31(12):1063-8
pubmed: 19246971
Endocrine. 2016 Apr;52(1):120-9
pubmed: 26306774
Thyroid. 2006 Jun;16(6):573-82
pubmed: 16839259
J Clin Transl Endocrinol. 2018 Nov 23;15:12-18
pubmed: 30555788
Thyroid. 2016 Feb;26(2):296-305
pubmed: 26586553
Thyroid. 2011 Oct;21(10):1081-125
pubmed: 21787128
J Clin Endocrinol Metab. 2012 Feb;97(2):334-42
pubmed: 22312089
Endocrine. 2019 Jul;65(1):94-101
pubmed: 30840228
Thyroid. 2017 Mar;27(3):315-389
pubmed: 28056690
Br Med J (Clin Res Ed). 1988 Jan 23;296(6617):241-4
pubmed: 3124900